Is It Too Late to Buy Madrigal Pharmaceuticals Stock?

Will being the first to its market ensure that its future is bright? With shares of Madrigal Pharmaceuticals (MDGL -1.12%) up by 220% over the last three years, it's easy to see why investors might get the idea that there isn't much upside left with this biotech stock. Without much in the way of media buzz, its future accomplishments, assuming there are any, might not even get noticed by the market -- so the argument goes. But is it actually too late to buy this stock, or is there still an opportunity? Taki ...